{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:59:52Z","timestamp":1785164392687,"version":"3.55.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-25869-6","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:48:35Z","timestamp":1764082115000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Protective role of fucoidan against cognitive deficits and redox imbalance in a scopolamine-induced Alzheimer\u2019s disease model in rats"],"prefix":"10.1038","volume":"15","author":[{"given":"Maryam","family":"Salmani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdieh","family":"Anoush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Kalantari-Hesari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Jahani-Maleki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Nouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6300-7398","authenticated-orcid":false,"given":"Mir-Jamal","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3957-2781","authenticated-orcid":false,"given":"Mojdeh","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"25869_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure, M. A. & Dickson, D. W. The neuropathological diagnosis of alzheimer\u2019s disease. Mol. Neurodegeneration. 14, 32 (2019).","journal-title":"Mol. Neurodegeneration"},{"key":"25869_CR2","doi-asserted-by":"crossref","unstructured":"Rocca, W. A. & Amaducci, L. Epidemiology of Alzheimer\u2019s disease. Neuroepidemiology 55\u201396 (2019).","DOI":"10.1201\/9780429277276-6"},{"key":"25869_CR3","unstructured":"Rybakowski, J. K. et al. Lithium in Alzheimer\u2019s disease: experimentpidemiological and clinical findings. Alzheimer\u2019s Disease. The 21st Century Challenge, eds J. Dorszewska and W. Kozubski (London: IntechOpen), 79\u201389 (2018)."},{"key":"25869_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman, D. S. et al. Alzheimer disease. Nat. Reviews Disease Primers. 7, 33 (2021).","journal-title":"Nat. Reviews Disease Primers"},{"key":"25869_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s13205-022-03123-4","volume":"12","author":"YL Rao","year":"2022","unstructured":"Rao, Y. L. et al. Hippocampus and its involvement in alzheimer\u2019s disease: a review. 3 Biotech. 12, 55 (2022).","journal-title":"3 Biotech."},{"key":"25869_CR6","doi-asserted-by":"crossref","unstructured":"Goverdhan, P., Sravanthi, A. & Mamatha, T. Neuroprotective effects of meloxicam and selegiline in scopolamine-induced cognitive impairment and oxidative stress. Int. J. Alzheimer\u2019s Dis. 2012 974013 (2012).","DOI":"10.1155\/2012\/974013"},{"key":"25869_CR7","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.pbb.2008.03.029","volume":"90","author":"J Chen","year":"2008","unstructured":"Chen, J. et al. Water-soluble derivative of propolis mitigates scopolamine-induced learning and memory impairment in mice. Pharmacol. Biochem. Behav. 90, 441\u2013446 (2008).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"25869_CR8","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.neubiorev.2010.04.001","volume":"34","author":"I Klinkenberg","year":"2010","unstructured":"Klinkenberg, I. & Blokland, A. The validity of scopolamine as a Pharmacological model for cognitive impairment: a review of animal behavioral studies. Neurosci. Biobehavioral Reviews. 34, 1307\u20131350 (2010).","journal-title":"Neurosci. Biobehavioral Reviews"},{"key":"25869_CR9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ijdevneu.2005.11.010","volume":"24","author":"W Liskowsky","year":"2006","unstructured":"Liskowsky, W. & Schliebs, R. Muscarinic acetylcholine receptor Inhibition in Transgenic Alzheimer-like Tg2576 mice by scopolamine favours the amyloidogenic route of processing of amyloid precursor protein. Int. J. Dev. Neurosci. 24, 149\u2013156 (2006).","journal-title":"Int. J. Dev. Neurosci."},{"key":"25869_CR10","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.1073\/pnas.0709180105","volume":"105","author":"C A Dickey","year":"2008","unstructured":"A Dickey, C. et al. Akt and CHIP coregulate Tau degradation through coordinated interactions. Proc. Natl. Acad. Sci. 105, 3622\u20133627 (2008).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"25869_CR11","doi-asserted-by":"publisher","first-page":"e27265","DOI":"10.1371\/journal.pone.0027265","volume":"6","author":"A Konar","year":"2011","unstructured":"Konar, A. et al. Protective role of Ashwagandha leaf extract and its component withanone on scopolamine-induced changes in the brain and brain-derived cells. PloS One. 6, e27265 (2011).","journal-title":"PloS One"},{"key":"25869_CR12","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1586\/ern.09.23","volume":"9","author":"N Tsuno","year":"2009","unstructured":"Tsuno, N. Donepezil in the treatment of patients with alzheimer\u2019s disease. Expert Rev. Neurother. 9, 591\u2013598 (2009).","journal-title":"Expert Rev. Neurother."},{"key":"25869_CR13","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3233\/JAD-170672","volume":"62","author":"J Folch","year":"2018","unstructured":"Folch, J. et al. Memantine for the treatment of dementia: a review on its current and future applications. J. Alzheimers Dis. 62, 1223\u20131240 (2018).","journal-title":"J. Alzheimers Dis."},{"key":"25869_CR14","doi-asserted-by":"publisher","first-page":"108352","DOI":"10.1016\/j.neuropharm.2020.108352","volume":"190","author":"G Marucci","year":"2021","unstructured":"Marucci, G. et al. Efficacy of acetylcholinesterase inhibitors in alzheimer\u2019s disease. Neuropharmacology 190, 108352 (2021).","journal-title":"Neuropharmacology"},{"key":"25869_CR15","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1046\/j.1365-2125.1999.00026.x","volume":"48","author":"B McGleenon","year":"1999","unstructured":"McGleenon, B., Dynan, K. & Passmore, A. Acetylcholinesterase inhibitors in alzheimer\u2019s disease. Br. J. Clin. Pharmacol. 48, 471 (1999).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"25869_CR16","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.3390\/ijms21093272","volume":"21","author":"MT Kabir","year":"2020","unstructured":"Kabir, M. T. et al. Combination drug therapy for the management of alzheimer\u2019s disease. Int. J. Mol. Sci. 21, 3272 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"25869_CR17","doi-asserted-by":"crossref","unstructured":"Hosseini, M. J. et al. Protective effects of Vinca herbaceous extract against scopolamine-induced behavioral disturbances and brain oxidative stress in rats. Heliyon 8 (2022).","DOI":"10.1016\/j.heliyon.2022.e09295"},{"key":"25869_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2174\/138161212798919002","volume":"18","author":"H Geun Kim","year":"2012","unstructured":"Geun Kim, H. Sook Oh, M. Herbal medicines for the prevention and treatment of alzheimer\u2019s disease. Curr. Pharm. Design. 18, 57\u201375 (2012).","journal-title":"Curr. Pharm. Design"},{"key":"25869_CR19","doi-asserted-by":"publisher","first-page":"147517","DOI":"10.1016\/j.brainres.2021.147517","volume":"1766","author":"N Ahmadi","year":"2021","unstructured":"Ahmadi, N., Hosseini, M. J., Rostamizadeh, K. & Anoush, M. Investigation of therapeutic effect of Curcumin \u03b1 and \u03b2 glucoside anomers against alzheimer\u2019s disease by the nose to brain drug delivery. Brain Res. 1766, 147517 (2021).","journal-title":"Brain Res."},{"key":"25869_CR20","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3390\/md17090487","volume":"17","author":"S Luthuli","year":"2019","unstructured":"Luthuli, S. et al. Therapeutic effects of fucoidan: A review on recent studies. Mar. Drugs. 17, 487 (2019).","journal-title":"Mar. Drugs"},{"key":"25869_CR21","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.etap.2011.12.022","volume":"33","author":"Y Gao","year":"2012","unstructured":"Gao, Y. et al. Fucoidan, a sulfated polysaccharide from brown algae, improves cognitive impairment induced by infusion of A\u03b2 peptide in rats. Environ. Toxicol. Pharmacol. 33, 304\u2013311 (2012).","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"25869_CR22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.pathophys.2006.05.004","volume":"13","author":"V Chauhan","year":"2006","unstructured":"Chauhan, V. & Chauhan, A. Oxidative stress in alzheimer\u2019s disease. Pathophysiology 13, 195\u2013208 (2006).","journal-title":"Pathophysiology"},{"key":"25869_CR23","doi-asserted-by":"crossref","unstructured":"Anoush, M. et al. Edaravone improves streptozotocin-induced memory impairment via alleviation of behavioral dysfunction, oxidative stress, inflammation, and histopathological parameters. Behav. Neurol. 2023 9652513 (2023).","DOI":"10.1155\/2023\/9652513"},{"key":"25869_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1006\/exnr.1997.6750","volume":"150","author":"DL Marcus","year":"1998","unstructured":"Marcus, D. L. et al. Increased peroxidation and reduced antioxidant enzyme activity in alzheimer\u2019s disease. Exp. Neurol. 150, 40\u201344 (1998).","journal-title":"Exp. Neurol."},{"key":"25869_CR25","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3389\/fncel.2015.00322","volume":"9","author":"JE Yuste","year":"2015","unstructured":"Yuste, J. E., Tarragon, E., Campuzano, C. M. & Ros-Bernal, F. Implications of glial nitric oxide in neurodegenerative diseases. Front. Cell. Neurosci. 9, 322 (2015).","journal-title":"Front. Cell. Neurosci."},{"key":"25869_CR26","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1007\/s11064-008-9593-0","volume":"33","author":"R Sultana","year":"2008","unstructured":"Sultana, R., Piroddi, M., Galli, F. & Butterfield, D. A. Protein levels and activity of some antioxidant enzymes in hippocampus of subjects with amnestic mild cognitive impairment. Neurochem. Res. 33, 2540\u20132546 (2008).","journal-title":"Neurochem. Res."},{"key":"25869_CR27","first-page":"230","volume":"13","author":"ID Kurnialahi","year":"2020","unstructured":"Kurnialahi, I. D., Husni, A., Sinurat, E. & Isnansetyo, A. Antioxidant activity of tropical seaweed sargassum muticum fucoidan. Aquaculture Aquarium Conserv. Legislation. 13, 230\u2013240 (2020).","journal-title":"Aquaculture Aquarium Conserv. Legislation"},{"key":"25869_CR28","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3923\/pjbs.2014.402.407","volume":"17","author":"T Marudhupandi","year":"2014","unstructured":"Marudhupandi, T., Kumar, T., Senthil, S. L. & Devi, K. N. In vitro antioxidant properties of fucoidan fractions from sargassum tenerrimum. Pak J. Biol. Sci. 17, 402\u2013407 (2014).","journal-title":"Pak J. Biol. Sci."},{"key":"25869_CR29","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","volume":"377","author":"C Ballard","year":"2011","unstructured":"Ballard, C. et al. Alzheimer\u2019s disease. Lancet 377, 1019\u20131031 (2011).","journal-title":"Lancet"},{"key":"25869_CR30","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.3233\/JAD-2010-100975","volume":"22","author":"VH Finder","year":"2010","unstructured":"Finder, V. H. Alzheimer\u2019s disease: a general introduction and pathomechanism. J. Alzheimers Dis. 22, S5\u2013S19 (2010).","journal-title":"J. Alzheimers Dis."},{"key":"25869_CR31","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.neuint.2011.12.013","volume":"60","author":"Q Chen","year":"2012","unstructured":"Chen, Q. et al. Tau protein is involved in morphological plasticity in hippocampal neurons in response to BDNF. Neurochem. Int. 60, 233\u2013242 (2012).","journal-title":"Neurochem. Int."},{"key":"25869_CR32","doi-asserted-by":"publisher","first-page":"3820","DOI":"10.1039\/D0FO03153D","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Fucoidan: a promising agent for brain injury and neurodegenerative disease intervention. Food Funct. 12, 3820\u20133830 (2021).","journal-title":"Food Funct."},{"key":"25869_CR33","doi-asserted-by":"publisher","first-page":"6143","DOI":"10.1007\/s11033-020-05696-w","volume":"47","author":"H Mozafari","year":"2020","unstructured":"Mozafari, H. et al. Minocycline attenuates depressive-like behaviors in mice treated with the low dose of intracerebroventricular streptozotocin; the role of mitochondrial function and neuroinflammation. Mol. Biol. Rep. 47, 6143\u20136153 (2020).","journal-title":"Mol. Biol. Rep."},{"key":"25869_CR34","doi-asserted-by":"publisher","first-page":"6518","DOI":"10.3390\/ijms24076518","volume":"24","author":"B Twarowski","year":"2023","unstructured":"Twarowski, B. & Herbet, M. Inflammatory processes in alzheimer\u2019s Disease\u2014Pathomechanism, diagnosis and treatment: A review. Int. J. Mol. Sci. 24, 6518 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"25869_CR35","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/0091-3057(86)90158-9","volume":"25","author":"EL Spangler","year":"1986","unstructured":"Spangler, E. L., Rigby, P. & Ingram, D. K. Scopolamine impairs learning performance of rats in a 14-unit T-maze. Pharmacol. Biochem. Behav. 25, 673\u2013679 (1986).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"25869_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2741\/e855","volume":"12","author":"M Subaraja","year":"2020","unstructured":"Subaraja, M. et al. Fucoidan serves a neuroprotective effect in an alzheimer\u2019s disease model. Front. Bioscience-Elite. 12, 1\u201334 (2020).","journal-title":"Front. Bioscience-Elite"},{"key":"25869_CR37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ejphar.2009.06.015","volume":"617","author":"D Luo","year":"2009","unstructured":"Luo, D. et al. Fucoidan protects against dopaminergic neuron death in vivo and in vitro. Eur. J. Pharmacol. 617, 33\u201340 (2009).","journal-title":"Eur. J. Pharmacol."},{"key":"25869_CR38","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s10072-012-1263-y","volume":"34","author":"R Yang","year":"2013","unstructured":"Yang, R. et al. Monosialoanglioside improves memory deficits and relieves oxidative stress in the hippocampus of rat model of alzheimer\u2019s disease. Neurol. Sci. 34, 1447\u20131451 (2013).","journal-title":"Neurol. Sci."},{"key":"25869_CR39","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.neulet.2009.11.033","volume":"469","author":"M Padurariu","year":"2010","unstructured":"Padurariu, M. et al. Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and alzheimer\u2019s disease. Neurosci. Lett. 469, 6\u201310 (2010).","journal-title":"Neurosci. Lett."},{"key":"25869_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13205-021-02879-5","volume":"11","author":"YL Rao","year":"2021","unstructured":"Rao, Y. L. et al. Comparison of malondialdehyde levels and superoxide dismutase activity in Resveratrol and Resveratrol\/donepezil combination treatment groups in alzheimer\u2019s disease induced rat model. 3 Biotech. 11, 1\u201310 (2021).","journal-title":"3 Biotech."},{"key":"25869_CR41","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12640-009-9066-5","volume":"16","author":"G Aliev","year":"2009","unstructured":"Aliev, G. et al. Nitric oxide as an initiator of brain lesions during the development of alzheimer disease. Neurotox. Res. 16, 293\u2013305 (2009).","journal-title":"Neurotox. Res."},{"key":"25869_CR42","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1179\/016164103101201931","volume":"25","author":"J De la Torre","year":"2003","unstructured":"De la Torre, J. et al. Hippocampal nitric oxide upregulation precedes memory loss and A \u03b2 1\u201340 accumulation after chronic brain hypoperfusion in rats. Neurol. Res. 25, 635\u2013641 (2003).","journal-title":"Neurol. Res."},{"key":"25869_CR43","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/j.1440-1681.2009.05314.x","volume":"37","author":"YQ Cui","year":"2010","unstructured":"Cui, Y. Q. et al. Inhibitory effect of fucoidan on nitric oxide production in lipopolysaccharide-activated primary microglia. Clin. Exp. Pharmacol. Physiol. 37, 422\u2013428 (2010).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"25869_CR44","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1080\/10715760802255764","volume":"42","author":"J Greilberger","year":"2008","unstructured":"Greilberger, J. et al. Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and alzheimer\u2019s disease. Free Radic. Res. 42, 633\u2013638 (2008).","journal-title":"Free Radic. Res."},{"key":"25869_CR45","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s10735-021-09998-6","volume":"52","author":"DA Mandour","year":"2021","unstructured":"Mandour, D. A., Bendary, M. & Alsemeh, A. E. Histological and imunohistochemical alterations of hippocampus and prefrontal cortex in a rat model of alzheimer like-disease with a Preferential role of the flavonoid hesperidin. J. Mol. Histol. 52, 1043\u20131065 (2021).","journal-title":"J. Mol. Histol."},{"key":"25869_CR46","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ijbiomac.2015.12.025","volume":"86","author":"S Meenakshi","year":"2016","unstructured":"Meenakshi, S., Umayaparvathi, S., Saravanan, R., Manivasagam, T. & Balasubramanian, T. Neuroprotective effect of fucoidan from turbinaria decurrens in MPTP intoxicated parkinsonic mice. Int. J. Biol. Macromol. 86, 425\u2013433 (2016).","journal-title":"Int. J. Biol. Macromol."},{"key":"25869_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2741\/e855","volume":"12","author":"M Subaraja","year":"2020","unstructured":"Subaraja, M. et al. Fucoidan serves a neuroprotective effect in an alzheimer\u2019s disease model. FBE 12, 1\u201334. https:\/\/doi.org\/10.2741\/e855 (2020).","journal-title":"FBE"},{"key":"25869_CR48","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3390\/md21020112","volume":"21","author":"YA Haggag","year":"2023","unstructured":"Haggag, Y. A., Abd Elrahman, A. A., Ulber, R. & Zayed, A. Fucoidan in pharmaceutical formulations: a comprehensive review for smart drug delivery systems. Mar. Drugs. 21, 112 (2023).","journal-title":"Mar. Drugs"},{"key":"25869_CR49","doi-asserted-by":"crossref","unstructured":"Lueptow, L. M. Novel object recognition test for the investigation of learning and memory in mice. JoVE (J.  Vis. Exp.) e55718 (2017).","DOI":"10.3791\/55718-v"},{"key":"25869_CR50","doi-asserted-by":"publisher","first-page":"430","DOI":"10.34172\/apb.2020.052","volume":"10","author":"F Berahmand","year":"2020","unstructured":"Berahmand, F., Anoush, G., Hosseini, M. J. & Anoush, M. Grape seed oil as a natural therapy in male rats with alzheimer\u2019s diseases. Adv. Pharm. Bull. 10, 430 (2020).","journal-title":"Adv. Pharm. Bull."},{"key":"25869_CR51","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1093\/hmg\/ddy042","volume":"27","author":"M Manczak","year":"2018","unstructured":"Manczak, M., Kandimalla, R., Yin, X. & Reddy, P. H. Hippocampal mutant APP and amyloid beta-induced cognitive decline, dendritic spine loss, defective autophagy, mitophagy and mitochondrial abnormalities in a mouse model of alzheimer\u2019s disease. Hum. Mol. Genet. 27, 1332\u20131342 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"25869_CR52","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/hmg\/ddx381","volume":"27","author":"R Kandimalla","year":"2018","unstructured":"Kandimalla, R., Manczak, M., Yin, X., Wang, R. & Reddy, P. H. Hippocampal phosphorylated Tau induced cognitive decline, dendritic spine loss and mitochondrial abnormalities in a mouse model of alzheimer\u2019s disease. Hum. Mol. Genet. 27, 30\u201340 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"25869_CR53","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/10715760290006411","volume":"36","author":"K Schlesier","year":"2002","unstructured":"Schlesier, K., Harwat, M., B\u00f6hm, V. & Bitsch, R. Assessment of antioxidant activity by using different in vitro methods. Free Radic. Res. 36, 177\u2013187 (2002).","journal-title":"Free Radic. Res."},{"key":"25869_CR54","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa, H., Ohishi, N. & Yagi, K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95, 351\u2013358 (1979).","journal-title":"Anal. Biochem."},{"key":"25869_CR55","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1007\/s00394-015-1024-9","volume":"55","author":"JM Rubio-Perez","year":"2016","unstructured":"Rubio-Perez, J. M., Albaladejo, M. D., Zafrilla, P., Vidal-Guevara, M. L. & Morillas-Ruiz, J. M. Effects of an antioxidant beverage on biomarkers of oxidative stress in alzheimer\u2019s patients. Eur. J. Nutr. 55, 2105\u20132116 (2016).","journal-title":"Eur. J. Nutr."},{"key":"25869_CR56","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.etap.2016.06.008","volume":"45","author":"M Dobrakowski","year":"2016","unstructured":"Dobrakowski, M. et al. Glutathione, glutathione-related enzymes, and oxidative stress in individuals with subacute occupational exposure to lead. Environ. Toxicol. Pharmacol. 45, 235\u2013240 (2016).","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"25869_CR57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0009-8981(03)00003-2","volume":"329","author":"I Dalle-Donne","year":"2003","unstructured":"Dalle-Donne, I., Rossi, R., Giustarini, D., Milzani, A. & Colombo, R. Protein carbonyl groups as biomarkers of oxidative stress. Clin. Chim. Acta. 329, 23\u201338 (2003).","journal-title":"Clin. Chim. Acta"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25869-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25869-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25869-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T16:04:34Z","timestamp":1764086674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25869-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25869"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-25869-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"16 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures in this study were conducted in accordance with the protocols approved by the Hamedan University of Medical Sciences ethical committee (IR.UMSHA.REC.1401.769) for the care and use of laboratory animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"41813"}}